Biologics Manufacturing Japan 2021
The ONLY event in Japan connecting you to Japan’s key biologics, vaccines & cell therapy players!Download Brochure
Showcase Your Solutions
Thought Leadership, Product Showcase, Branding, Lead Generation & Other Opportunities Available.Download Sponsorship Prospectus
Connect with the Event Participants through our event app
Explore Endless Learning & Networking Opportunities On Our Virtual Event Platform!Download Brochure
Home to the second-largest pharmaceutical market in the world, Japan has poised itself as one of the most lucrative biotech hubs in Asia, and worldwide. Over recent years, the Japanese biologics market has opened its doors to both foreign companies entering the Japanese market and companies investing abroad. Japan’s biopharma sector has had a keen eye on alliance opportunities in markets beyond its borders and although the nature of its sector is a cautious one, its move towards transparency and international collaboration provides bountiful opportunities that both the domestic and international players stand to benefit from.
The 2nd edition of the Biologics Manufacturing Japan 2021, aims to provide a neutral platform to address the challenges faced in this sector including high costs incurred in the downstream purification of highly complex molecules, purification process development to maximize process economy, difficulties in process development, scale-up and technology transfer for biologics, reduction of Cost-of-Goods for large-scale manufacturing, insights into the regulatory perspective on common pitfalls in analytical and CMC studies, Single-Use Systems in USP & DSP and Cost-Benefit analysis of CMO outsourcing strategies.
Join the conference to interact with key and upcoming entities from Japanese Biologics space include Chugai Pharmaceutical, Kyowa Hakko Kirin, UMN Pharma, Daiichi Sankyo, Daiichi Sankyo, Asahi Glass Co., Astellas Pharma and Fujifilm Holdings Corp among others.
Biologics Manufacturing Japan will once again serve as the only bioprocessing focused platform in Japan for global partners and local stakeholders to leverage partnership opportunities, scientific innovation and manufacturing best practice case studies. This event will see the complete network of BIG Pharma, International Biopharma, Japanese Biopharma, Contract Manufacturing Organisations, Academic & Research Institutes, Regulatory Authorities, Solution Providers and Technocrats under one roof. If Japan is the country you are looking at for plentiful opportunities in the bio-manufacturing space, then Biologics Manufacturing Japan 2021 is where you have to be!
To become a speaker yourself at the 2021 event, contact: Joey Park, Conference Producer, T: +65 3109 0124, E: email@example.com
Jun Hu Wuxi Biologics
Sushant Sahastrabuddhe International Vaccine Institute
Nikolai Petrovsky Vaxine Pty Ltd
Dr. Raj Shankar Ghosh Bill and Melinda Gates Foundation
Harkabir Jandu Clinton Health Access Initiative
Andrew Wong Shanghai Zerun Biotechnology
Pierre A. Morgon Eurocine Vaccines, NED, Vaccitech, NED, Univercells
Dinesh Khokal Amgen
Prof Maria Elena Bottazzi Baylor College of Medicine
Hiroyuki Moriuchi Nagasaki University Graduate School of Biomedical Sciences & School of Tropical Medicine and Global Health
Dr. Asel Sartbaeva University of Bath
Dr. Zoltán Kis Imperial College London
Uwe Voelker Roche
Yong Jick Kim Polus Inc.
Shuichi Yamamoto Yamaguchi University Biomedical Engineering Center
Yoshikazu Honda-Okubo Vaxine
Biologics Manufacturing Japan will provide commercial organizations with the opportunity to educate the market by raising brand awareness and positioning yourselves as leaders in the field. By maximizing face time with key profiles from biologics manufacturers from the region regulators and national health organizations all in a single location, you will enjoy the option of privately arranged meetings and consultations with selected potential clients.